1. Home
  2. SPCE vs VYGR Comparison

SPCE vs VYGR Comparison

Compare SPCE & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virgin Galactic Holdings Inc.

SPCE

Virgin Galactic Holdings Inc.

HOLD

Current Price

$3.86

Market Cap

226.9M

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$4.08

Market Cap

232.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPCE
VYGR
Founded
2017
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
226.9M
232.4M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
SPCE
VYGR
Price
$3.86
$4.08
Analyst Decision
Hold
Strong Buy
Analyst Count
5
7
Target Price
$10.60
$16.17
AVG Volume (30 Days)
3.0M
468.8K
Earning Date
11-13-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,661,000.00
$31,316,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2,908.26
$107.10
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.18
$2.65
52 Week High
$7.59
$7.44

Technical Indicators

Market Signals
Indicator
SPCE
VYGR
Relative Strength Index (RSI) 57.14 43.85
Support Level $3.20 $3.91
Resistance Level $3.79 $4.30
Average True Range (ATR) 0.25 0.25
MACD 0.03 -0.00
Stochastic Oscillator 97.79 46.61

Price Performance

Historical Comparison
SPCE
VYGR

About SPCE Virgin Galactic Holdings Inc.

Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: